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Myocardial injury with an elevated concentration of cardiac troponins is a prevalent 
condition associated with increased in-hospital mortality in patients with coronavirus disease-
2019 (COVID-19) [1]. Myocarditis may be the underlying pathology in some patients with 
COVID-19-related myocardial injury. Additionally, a substantial proportion of patients who 
have recovered from COVID-19 pneumonia present with persistent symptoms indicating 
sustained cardiac involvement. Therefore, it is of major clinical importance to investigate the 
association between cardiac symptoms and possible myocardial lesions in post-COVID-19 
patients.
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Cardiac magnetic resonance (CMR) is considered the gold standard to assess cardiac 
morphology and function. Moreover, unlike other imaging modalities, it allows for detailed 
tissue characterization.
In this research letter, we report on the findings of a pilot study including patients with
a history of recent COVID-19 pneumonia confirmed by a positive RT-PCR test and referred to
our outpatient post-COVID-19 cardiology clinic. This paper is focused on types of lesions and
their prevalence observed in CMR imaging. The TRICITY-CMR trial was designed as a 
prospective, cohort study including patients presenting with symptoms suggesting the 
involvement of the heart (e.g., chest pain, palpitations, dyspnea). In all the study participants, 
extracardiac etiology of symptoms seemed unlikely based on available test results. We 
excluded patients with any known previous cardiac pathology except essential hypertension as
well as those with contraindications for CMR imaging. Clinical data and CMR imaging were 
analyzed. The study protocol was approved by the local ethics committee, and subsequently 
all patients provided informed written consent. Patients were recruited between December 
2020 and March 2021. CMR was performed on a 1.5-T scanner (Magnetom Aera or 
Magnetom Sola, Siemens AG, Erlangen, Germany), and the protocol included standard long-
axis and short-axis cine series for anatomy and functional assessment, followed by cardiac 
parametric mapping (MyoMaps, Siemens Healthineers, Erlangen, Germany) and late 
gadolinium enhancement (LGE) (free breathing phase-sensitive inversion recovery, motion-
corrected [PSIR MOCO] sequence) for tissue characterization [2].
Fifty consecutive patients experiencing persistent cardiac symptoms after recovery 
from COVID-19 were included in the study. The mean age of patients was 47.3 ± 10.1 (range 
27–69) years, and 40% (n = 20) were men. Most of the patients reported dyspnea (50%; n = 
25) or fatigue (36%; n = 18) as the predominant complaint. Nearly one-third of the study 
participants (30%; n = 15) had a previous history of hypertension, and 14 (28%) individuals 
were obese. The mean time from the diagnosis of COVID-19 infection to the CMR 
examination was 51.5 ± 28.0 (range 11–113) days. Twenty-one (42%) study participants 
required hospitalization during the acute phase of COVID-19 infection. Among them, 15 
(71%) required supplemental oxygen therapy, 5 (24%) received remdesivir, 15 (71%) steroids,
and 3 (14%) were treated with convalescent plasma. Thirty-four (68%) patients were qualified
as moderately ill and 16 (32%) as severely ill.
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Cardiac involvement was confirmed by CMR in 30 (60%) patients. Reduced left 
ventricular systolic function according to institutional thresholds based on the literature [3] 
(i.e., left ventricular ejection fraction [LVEF] < 57%) was found in 4 (8%) patients. None of 
the patients had reduced right ventricular systolic function (i.e., right ventricular ejection 
fraction [RVEF] < 52% in men and < 51% in women) [3].
Late gadolinium enhancement was present in 30 (60%) patients. In this sub-group, 
60% (n = 18) had at least 2-segment involvement. Three-segment involvement was seen in 4 
(13%) cases and 3 (10%) patients had 4-segment involvement. Most LGE lesions were 
located at inferolateral (76%, n = 23) and inferior (43%, n = 13) segments at base. 
Additionally, among patients with LGE, in 2 cases markedly elevated native T1 and T2 values
were shown, suggestive of ongoing myocardial inflammation. Small pericardial effusion was 
found in 1 patient. Figure 1 illustrates typical CMR findings noted in our patients.
Importantly, our study demonstrated abnormal CMR findings in the majority of 
symptomatic patients with recent COVID-19 pneumonia. The most common finding was 
LGE, predominantly located in the basal inferolateral or inferior segments. A relatively low 
prevalence of active myocardial inflammation with T1 and T2 myocardial mapping was 
revealed.
Our findings correspond with a previously reported high incidence of myocardial 
injury secondary to COVID-19 infection [1]. Puntmann et al. [4], in their study of 100 
unselected patients after recent COVID-19 pneumonia using CMR imaging, showed cardiac 
involvement in 78% of participants and ongoing myocardial inflammation in 60% of cases. 
These findings were independent of preexisting conditions, severity and overall course of 
acute illness, and time from the original diagnosis. Positive LGE with patterns typically 
occurring in myocarditis was described in prior case reports and observational studies in post-
COVID-19 patients [5, 6]. It is worth emphasizing that the presence of LGE is considered a 
strong predictor of adverse clinical outcome [7]. Additionally, recent CMR mapping 
techniques enable quantitative detection of myocardial edema, inflammation, or diffuse 
fibrosis. In our study group, increased native T1 and T2 values suggestive of ongoing 
myocarditis were observed in 2 (4%) cases, similar to a previous report by Brito et al. [8] and 
in contrast with the aforementioned study by Puntmann et al. [4]. These apparent 
discrepancies in the literature should be analyzed with all due consideration regarding cohort 
characteristics (e.g., age, co-morbidities, disease severity, time from diagnosis). This also 
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underlines the role of the parametric mapping sequences because they quantitatively assess 
ongoing inflammation and can shed light on the evolution of COVID-19-related myocardial 
injury. It should be emphasized, however, that mapping techniques are intrinsically complex 
and can be methodologically challenging. Therefore, to provide reliable insight, they must be 
utilized according to the guidelines, and institution-specific reference ranges should be 
established [9]. A prior study indicated that native T1 and myocardial extracellular volume 
values are independent risk factors of adverse clinical outcomes in dilated cardiomyopathy 
[10].
The results of this pilot study indicate the necessity of continued cardiological 
evaluation of patients with persistent symptoms of possible cardiac origin after recovery from 
COVID-19 pneumonia. Our findings confirm that persistence of cardiac symptoms after 
COVID-19 recovery may be related to the heart involvement. Future research is needed to 
determine the potential clinical significance of CMR findings observed in post-COVID-19 
patients.
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Figure 1. Typical lesions found in cardiac magnetic resonance examination in patients with a 
history of recent COVID-19 pneumonia and symptoms suggesting cardiac involvement. A. 
Locally (blue arrows) increased T2 (left) and T1 (middle) relaxation times pointing out areas 
of acute injury/ongoing inflammation, paralleled by subtle intramyocardial areas of 
irreversible damage (inflammatory necrosis/fibrosis) as shown by late gadolinium 
enhancement (LGE) (right) in a 63-year-old patient about 6 weeks post COVID-19 
pneumonia. Global T2 relaxation time was 46 ms (the institutional reference range: 39–49 ms)
with local (arrows) increase (segmental ROI average values T2 = 52 ms in the basal septal, T2
= 52 ms in the basal inferior, and 53 ms in the basal posterior segments). Global T1 value was 
994 ms (the institutional reference range: 951–1035 ms) with local increase in the septum 
(1065 ms) as well as inferior (1050 ms) and posterior segments (1056 ms); B. Examples of 
LGE patterns in the study group (blue arrows); Left: Subtle subepicardial LGE in the basal 
inferior and/or posterior segment, representing the most common LGE pattern in our post-
COVID cohort; Middle: Intramyocardial areas of LGE in the basal septal, inferior, and 
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inferolateral segments; Right: Long-axis 3-chamber plane in the same patient, showing 
involvement of the basal inferolateral segment and the posterior papillary muscle.
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